Entera Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.31	7.11	8.66	11.02	12.31	24.89
Cash & Short-Term Investments	11.31	7.11	8.66	11.02	12.31	24.89
Cash Growth	4.15%	-17.92%	-21.41%	-10.48%	-50.55%	189.68%
Accounts Receivable	-	-	0.13	-	0.25	0.18
Other Receivables	0.11	0.22	-	-	-	-
Receivables	0.11	0.22	0.13	-	0.25	0.18
Prepaid Expenses	0.22	0.04	0.03	-	-	-
Restricted Cash	7.12	7.78	-	-	-	-
Other Current Assets	0.14	0.16	0.16	0.24	0.29	0.25
Total Current Assets	18.9	15.3	8.97	11.26	12.85	25.33
Property, Plant & Equipment	0.48	0.6	0.33	0.49	0.23	0.4
Long-Term Deferred Tax Assets	-	-	-	0.01	0.04	0.22
Other Long-Term Assets	0.1	0.1	0.09	0.01	0.01	0.05
Total Assets	19.48	15.99	9.39	11.77	13.13	25.99
Accounts Payable	0.58	0.45	0.13	0.08	0.02	0.17
Accrued Expenses	0.92	1.16	0.87	0.87	1.23	2.67
Current Portion of Leases	0.2	0.23	0.17	0.13	0.09	0.18
Current Income Taxes Payable	-	-	-	-	-	0.13
Current Unearned Revenue	-	-	-	-	-	0.02
Other Current Liabilities	0.41	0.37	-	-	-	-
Total Current Liabilities	2.1	2.2	1.18	1.09	1.34	3.16
Long-Term Leases	0.23	0.26	0.1	0.26	-	0.12
Pension & Post-Retirement Benefits	0.04	0.04	0.03	0.03	0.03	0.14
Other Long-Term Liabilities	9.85	0.39	-	-	-	-
Total Liabilities	12.21	2.89	1.31	1.38	1.37	3.42
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	143.41	138.43	121.97	114.73	107.21	104.95
Retained Earnings	-136.18	-125.37	-113.93	-104.39	-95.5	-82.43
Comprehensive Income & Other	0.04	0.04	0.04	0.04	0.04	0.04
Shareholders' Equity	7.27	13.1	8.08	10.39	11.75	22.57
Total Liabilities & Equity	19.48	15.99	9.39	11.77	13.13	25.99
Total Debt	0.43	0.49	0.27	0.39	0.09	0.3
Net Cash (Debt)	10.88	6.62	8.39	10.63	12.22	24.59
Net Cash Growth	2.15%	-21.10%	-21.08%	-13.00%	-50.31%	201.31%
Net Cash Per Share	0.23	0.14	0.22	0.37	0.42	0.94
Filing Date Shares Outstanding	173.14	46.62	45.42	35.48	28.81	28.8
Total Common Shares Outstanding	49.29	46.18	38.84	35.48	28.81	28.8
Working Capital	16.79	13.1	7.8	10.17	11.51	22.17
Book Value Per Share	0.15	0.28	0.21	0.29	0.41	0.78
Tangible Book Value	7.27	13.1	8.08	10.39	11.75	22.57
Tangible Book Value Per Share	0.15	0.28	0.21	0.29	0.41	0.78

SEC Filings: 10-K · 10-Q